The vision of MetaHeps is to increase access of patients to novel drugs by addressing DILI issues in drug development in an unrivaled and innovative approach:

Using our patented technology will


 improve benefit-risk assessment by providing unprecedeneted data on DILI cases


avoid financial losses due to unnecessary drug attrition


protect patients at risk by the developemt of novel biomarkers


reduce risks of drug development and provide patients access to urgently needed treatments